Camp Lejeune cancer lawsuit

The Latest Developments On Camp Lejeune Water Contamination

Highlights of significant developments concerning the health impact on those exposed to the contaminated water and the ongoing efforts for compensation

Monday, March 25, 2024 - The ongoing water contamination issue at Camp Lejeune, a Marine Corps Base in North Carolina, has sparked profound legal and health-related discussions. With a history dating back to the mid-20th century, when hazardous chemicals contaminated the base's water supply, affecting countless Marines, their families, and civilian workers, the story of Camp Lejeune is a distressing chapter in U.S. military history. Recent developments have brought new attention to Camp Lejeune Justice Act Claims and Camp Lejeune water lawsuits, underscoring the government's efforts to address the grievances of those affected. The Environmental Working Group's latest study has shed alarming light on the increased cancer rates among individuals stationed or employed at Camp Lejeune between 1972 and 1985. The study compared the cancer incidence rates with those of Camp Pendleton, a base not known to have had contaminated drinking water before 1986, revealing significantly higher rates of various cancers, including leukemia, lymphoma, and cancers affecting the lung, breast, larynx, esophagus, thyroid, and soft tissues at Camp Lejeune​​. This comprehensive research underscores the dire consequences of exposure to toxic chemicals, such as trichloroethylene (TCE), vinyl chloride, and benzene, all recognized as carcinogens by the Environmental Protection Agency.

In the face of these health crises, Camp Lejeune Justice Act Claims and Camp Lejeune water lawsuits have become pivotal mechanisms for seeking compensation and justice for the victims. The landmark PACT Act of 2022 included provisions that specifically allow those harmed by the contaminated water at Camp Lejeune to file damage claims with the Navy. If unresolved within six months, these claims can escalate to lawsuits filed in federal court in North Carolina​​. This legislative move marked a significant step toward recognizing and remedying the suffering endured by many due to the negligence at Camp Lejeune. However, the path to compensation has been fraught with challenges. While the government has begun offering settlements ranging from $100,000 to $550,000, depending on the exposure duration and severity of the disease contracted, many argue that these amounts fall short of addressing the full extent of the damages suffered. More than 1,100 cases have already been filed in federal court, indicating a strong preference among many victims and their legal representatives to pursue justice through litigation rather than settle for what they perceive as inadequate compensation​​.

For certain claimants, there is some hope for a speedier resolution with the latest government measures under the Camp Lejeune Justice Act Claim. However, given the intricacy and scope of the problem, it appears that the court cases--such as the Camp Lejeune water lawsuit--will go on for years. Both advocates and victims want the harm done to be acknowledged more thoroughly and that the victims' losses and suffering be adequately compensated. The suffering of the victims of Camp Lejeune also brings attention to a wider problem of environmental neglect in military operations and emphasizes the necessity of strong safeguards to shield service members and their families from such risks in the future. It serves as a sobering reminder of the care that is required for those who serve.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.